Genomic landscape of clinically advanced KRAS wild-type pancreatic ductal adenocarcinoma

INTRODUCTION: KRAS mutation is a common occurrence in Pancreatic Ductal Adenocarcinoma (PDA) and is a driver mutation for disease development and progression. KRAS wild-type PDA may constitute a distinct molecular and clinical subtype. We used the Foundation one data to analyze the difference in Gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashok Kumar, Prashanth, Serinelli, Serenella, Zaccarini, Daniel J., Huang, Richard, Danziger, Natalie, Janovitz, Tyler, Basnet, Alina, Sivapiragasam, Abirami, Graziano, Stephen, Ross, Jeffrey S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315669/
https://www.ncbi.nlm.nih.gov/pubmed/37404765
http://dx.doi.org/10.3389/fonc.2023.1169586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315669/
https://www.ncbi.nlm.nih.gov/pubmed/37404765
http://dx.doi.org/10.3389/fonc.2023.1169586

Ejemplares similares